TMEM167B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.415400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.215600E-01
Normal-vs-Stage2
2.353800E-01
Normal-vs-Stage3
7.218100E-02
Normal-vs-Stage4
8.783600E-01
Stage1-vs-Stage2
8.437600E-01
Stage1-vs-Stage3
2.855800E-01
Stage1-vs-Stage4
2.754000E-01
Stage2-vs-Stage3
2.337000E-01
Stage2-vs-Stage4
1.204830E-01
Stage3-vs-Stage4
2.374300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.223800E-01
Normal-vs-AfricanAmerican
7.112000E-01
Normal-vs-Asian
2.375600E-01
Caucasian-vs-AfricanAmerican
3.528000E-01
Caucasian-vs-Asian
5.704600E-01
AfricanAmerican-vs-Asian
3.589800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.147800E-01
Normal-vs-Female
2.930600E-01
Male-vs-Female
5.068800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.030050E-01
Normal-vs-Age(41-60Yrs)
5.363800E-01
Normal-vs-Age(61-80Yrs)
1.811350E-01
Normal-vs-Age(81-100Yrs)
9.727600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.725800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.926600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.008800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.580400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.376260E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.175000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.464500E-02
Normal-vs-Daily Drinker
2.322600E-01
Normal-vs-Weekly Drinker
7.253600E-02
Normal-vs-Occasional Drinker
6.720800E-01
Normal-vs-Social Drinker
4.034800E-01
Non Drinker-vs-Daily Drinker
4.362200E-01
Non Drinker-vs-Weekly Drinker
6.918400E-01
Non Drinker-vs-Occasional Drinker
6.099000E-03
Non Drinker-vs-Social Drinker
1.452800E-01
Daily Drinker-vs-Weekly Drinker
3.518800E-01
Daily Drinker-vs-Occasional Drinker
9.168300E-02
Daily Drinker-vs-Social Drinker
5.246000E-01
Weekly Drinker-vs-Occasional Drinker
1.159700E-02
Weekly Drinker-vs-Social Drinker
1.448780E-01
Occasional Drinker-vs-Social Drinker
3.575200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.637000E-01
Normal-vs-Grade 2
6.125800E-01
Normal-vs-Grade 3
6.511800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.033700E-02
Grade 1-vs-Grade 3
3.515400E-01
Grade 1-vs-Grade 4
3.637000E-01
Grade 2-vs-Grade 3
3.736800E-01
Grade 2-vs-Grade 4
6.125800E-01
Grade 3-vs-Grade 4
6.511800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.275250E-01
Normal-vs-NonDiabetic
2.100600E-01
Diabetic-vs-NonDiabetic
5.059600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.052400E-01
Normal-vs-NoPancreatitis
2.116400E-01
Pancreatitis-vs-NoPancreatitis
8.906400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.978600E-01
Normal-vs-N1
2.426200E-01
N0-vs-N1
8.577600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.645000E-01
Normal-vs-TP53-NonMutant
3.763400E-01
TP53-Mutant-vs-TP53-NonMutant
2.138400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
